Alpha Cognition
ACOG | NASDAQ
$7.83
-$0.47 (-5.66%)
At close: Nov 16, 2026, 4:00 PM ET
$7.83
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-5.66%
(1D)No price chart data available for 1D timeframe.
Rating
53
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #218/1021 (Top 21%)
Key Statistics
Market Data
Market Cap $171.13M
1D Range
7.83 8.30
52W Range
4.50 9.75
Valuation (TTM)
PE -5.67
PB 3.47
EV/EBITDA -4.49
Valuation (NTM)
Forward PE 0.23
Forward PEG -0.31
Price Target $18.50
Cash Flow
FCF Yield -18.0%
SBC Adj. FCF Yield -21.1%
SBC Impact -17.0%
Margins
Gross Margin 93.1%
Operating Margin -149.6%
FCF Margin -152.6%
Growth (CAGR)
Revenue 3Y | 5Y 109.7% |
86.6%
Dil EPS 3Y | 5Y 41.5% |
37.0%
FCF 3Y | 5Y -64.6% |
-24.5%
Returns
ROA -46.5%
ROE -53.5%
ROIC -54.0%
Financial Health
Net Cash
$37.8M
Current Ratio 7.13
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commer...
Sector Healthcare
Industry Biotechnology
Employees 71
IPO Date Nov 12, 2024
Website www.alphacognition.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 11, 2026
EPS
-$0.35
Miss -4.48%
YoY:
-328.92% REV
$7.78M
Beat +10.46%
YoY:
+177.75%Next Earnings
Mar 25, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$18.50
Upside
+136.27%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ACOG